Epstein-barr virus (EBV) gene expression in lymphoid B cells during acute infectious mononucleosis (IM) and clonality of the directly growing cell lines

International Journal of Cancer

Volumn 71, Issue 3, 1997, Pages 345-349

  Laytragoon Lewin, Nongnit ^a   Chen, Fu ^b   Avila Carino, Javier ^b   Klein, George ^b   Mellstedt, Håkan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY;

ARTICLE; B LYMPHOCYTE; CASE REPORT; CELL SURVIVAL; EPSTEIN BARR VIRUS; GENE EXPRESSION REGULATION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTIOUS MONONUCLEOSIS; LYMPHOCYTE CLONE; PRIORITY JOURNAL; VIRUS EXPRESSION; VIRUS NEUTRALIZATION;

ANTIGENS, VIRAL; B-LYMPHOCYTES; CELL LINE; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENE EXPRESSION; HERPESVIRUS 4, HUMAN; HUMANS; INFECTIOUS MONONUCLEOSIS; RNA, MESSENGER; TONSIL; TRANSCRIPTION, GENETIC; VIRAL MATRIX PROTEINS; VIRUS LATENCY;

EID: 0031007001     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970502)71:3<345::AID-IJC6>3.0.CO;2-Y     Document Type: Article

References (24)

1. BROWN, N., LIU, C., WANG, Y. and GARCIA, C., B cell lymphoproliferation and lymphomagenesis are associated with clonotypic intracellular terminal regions of the Epstein Barr virus. J. Virol., 62, 962-969 (1988).
2. CHEN, F., DIRENZO, L., ZOU. J., WINBERG, G., HU, L.F., KLEIN, E., KLEIN, G. and ERNBERG, I., A subpopulation of latently EBV infected normal B cells resemble Burkitt Iymphoma (BL) cells in expressing EBNA1 but not EBNA2 or LMP1. J. gen. Virol., 69, 131-138 (1995).
3. CHOMCZYSNKI, P. and SACCHI, N., Single step of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 150-159 (1987).
4. DEACON, E., PALLESEN, G., NIEDOBITEK, G., CROCKER, J., BROOKS, L., RICKINSON, A. and YOUNG, L., Epstein Barr virus and Hodgkin's diseases: transcriptional analysis of virus latency in the malignant cells. J. exp. Med., 177, 339-349 (1993).
5. HENDERSON, S., ROWE, M., GREGORY, C., CROOM-CARTER, D., WANG, F., LONGNECKER, R., KIEFF, E. and RICKiNSON, A., Induction of Bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell, 65, 1107-1115 (1991).
6. HENLE, W., HENLE, G. and HORWITZ, C., Epstein Barr virus specific diagnostic tests in infectious mononucleosis. Hum. Pathol., 5, 551-565 (1974).
7. HURLEY, E. and THORLEY-LAWSON, D., B cell activation and the establishment of Epstein Barr virus latency. J. exp. Med., 168, 2059-2075 (1988).
8. ISAACSON, P., SCHMID, C., PAN, L., WOTHERSPOON, A. and WRIGHT, D., Epstein-Barr virus latent membrane protein expression by Hodgkin and Reed-Sternberg-like cells in acute infectious mononucleosis, J. Pathol., 167, 267-271 (1992).
9. KLEIN, G., SVEDMYR, E., JONDAL, M. and PERSSON, P., EBV determined nuclear antigen (EBNA) positive cells in peripheral blood of infectious mononucleosis patients. Int. J. Cancer, 17, 2-26 (1976).
10. LEWIN, N., ÅMAN, P., ÅKERLUND, B., GUSTAVSSON, E., CARENFELT, C., LEJDEBORN, L., KLEIN, G. and KLEIN, E., Epstein-Barr virus-carrying B cells in the blood during acute infectious mononucleosis give rise to lymphoblastoid lines in vitro by release of transforming virus and by proliferation. Immunol. Lett., 26, 59-65 (1990).
11. LEWIN, N., AMAN, P., MASUCCI, M., KLEIN, E., KLEIN, G., OBERG, B., STRANDER, H., HENLE, W. and HENLE, G., Characterization of EBV-carrying B-cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outarowth. Int. J. Cancer, 39, 472-476 (1987).
12. LEWIN, N., CHEN, F., AVILA-CARINO, J., Zou, J., ERNBERG, I., MFLLSTEDT, H. and KLEIN, G., Epstein Barr virus (EBV)-carrying cells of a chronic lymphocytic leukemia (CLL) subpopulation express EBNA1 and LMPs but not EBNA2 in vivo. Int. J. Cancer, 63, 486-490 (1995).
13. PALLESEN, G., HAMILTON-DUTOIT, S., ROWE, M., LISSE, L, RALFKIAER, E., SANDEJ, K. and YOUNG. L., Expression of Epstein-Barr virus replicative proteins in AIDS-related non-Hodgkin's lymphoma cells. J. Pathol, 165, 289-299 (1991).
14. RAAB-TRAUB, N. and FLYNN, K., The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell, 47, 883-889 (1986).
15. REEDMAN, B. and KLEIN, G., Cellular localization of an Epstein Barr virus (EBV)-associated complement-fixing antigen in producer and nonproducer lymphoblastoid cell lines. Int. J. Cancer, 11, 499-520 (1973).
16. ROGER, R., WOISETSCHLAEGER, M. and SPECK, S., Alternative splicing dictates translational start in Epstein Barr virus transcripts. EMBO J., 9, 2273-2277 (1990).
17. ROWE, M, LEAR, A., CROOM-CARTER. D., DAMES, H. and RICKINSON, A., Three pathways of Epstein-Barr virus gene activation from EBNA1positive latency in B lymphocytes. J. Virol., 66, 122-131 (1992).
18. ROWE, M., ROWE, D., GREGORY, C., YOUNG, L., FARRELL, P., RUPANI, H. and RICKINSON, A., Differences in B cell growth phenotype reflect novel patterns of Epstein Barr virus latent sene expression in Burkitt's lymphoma cells. EMBO J., 6, 2743-2751 (1987).
19. SAMPLE, J., BROOKS, L., SAMPLE, C., YOUNG, L., ROWE, M., GREGORY, C., RICKINSON, A. and KIEFF, E., Restricted Epstein Barr virus protein expression in Burkitt lymphoma is due to a different Epstein Barr virus nuclear antigen 1 transcriptional initiation site. Proc. nut. Acad. Sci. (Wash.). 88, 6343-6347 (1991).
20. THORLEY-LAWSON, D., NADLER, L., BHAN, A. and SCHOOLEY, R., Blast-2 (EBVCS), an early cell surface marker of human B cell activation, is superinduced by EBV. J. Immunol., 134, 3007-3012 (1985).
21. TIERNEY, R., STEVEN, N., YOUNG, L. and RICKINSON, A., Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription durins primary infection and in the earner state. J. Virol., 68, 7374-7385 (1994).
22. WAHL, G., STERN, M. and STARK, G., Efficient transfer of larae DNA fragments from agarose gels to diazobenyloxy-methyl paper and rapid hybridization by usine dextrane sulfate. Proc. nat. Acad. Sci. (Wash.), 76, 3683-3687 (1979).
23. WANG, F., TSANG, S., KURILLA, M., COHEN, J. and KIEFF, E., Epstein Barr virus nuclear antigen-2 transactivates latent membrane protein LMP1. Virology. 64, 3407-3415 (1990).
24. WOISETSCHLAEGER, M., STROMINGER, J. and SPECK, S., Mutually exclusive use of viral promoters in Epstein Barr virus latently infected lymphocytes. Proc. nat. Acad. Sci. (Wash.), 86, 6498-6502 (1989).